000 | 01144 a2200337 4500 | ||
---|---|---|---|
005 | 20250517152605.0 | ||
264 | 0 | _c20190702 | |
008 | 201907s 0 0 cze d | ||
022 | _a0862-495X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSkaličková, S | |
245 | 0 | 0 |
_a[Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2]. _h[electronic resource] |
260 |
_bKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti _c |
||
300 |
_a177-179 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFullerenes _xadministration & dosage |
650 | 0 | 4 | _aGenes, BRCA2 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMutation |
700 | 1 | _aLöfelmann, M | |
700 | 1 | _aGargulák, M | |
700 | 1 | _aDočekalová, M | |
700 | 1 | _aRuttkay-Nedecký, B | |
700 | 1 | _aSuchý, P | |
700 | 1 | _aKepinská, M | |
700 | 1 | _aKizek, R | |
773 | 0 |
_tKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti _gvol. 30 _gno. Supplementum1 _gp. 177-179 |
|
999 |
_c27140980 _d27140980 |